Abstract:Orthogonal recreation of the signaling profile of a chemical synapse is a current challenge in neuroscience. This is due in part to the kinetics of synaptic signaling, where neurotransmitters are rapidly released and quickly cleared by active reuptake machinery. One strategy to produce a rapid rise in an orthogonally controlled signal is via photocaged compounds. In this work, photocaged compounds are employed to recreate both the rapid rise and equally rapid fall in activation at a chemical synapse. Specifically, a complementary pair of photocages based on BODIPY were conjugated to a 5-HT2C subtype-selective agonist, WAY-161503, and antagonist, N-desmethylclozapine, to generate "caged" versions of these drugs. These conjugates release the bioactive drug upon illumination with green light (agonist) or red light (antagonist). We report on the synthesis, characterization, and bioactivity testing of the conjugates against the 5-HT2C receptor. We then characterize the kinetics of photolysis quantitatively using HPLC and qualitatively in cell culture conditions stimulating live cells. The compounds are shown to be stable in the dark for 48 h at room temperature, yet photolyze rapidly when irradiated with visible light. In live cells expressing the 5-HT2C receptor, precise spatiotemporal control of the degree and length of calcium signaling is demonstrated. By loading both compounds in tandem and leveraging spectral multiplexing as a noninvasive method to control local small-molecule drug availability, we can reproducibly initiate and suppress intracellular calcium flux on a timescale not possible by traditional methods of drug dosing. These tools enable a greater spatiotemporal control of 5-HT2C modulation and will allow for more detailed studies of the receptors' signaling, interactions with other proteins, and native physiology.

"Photo‐Adrenalines": Photoswitchable β2‐Adrenergic Receptor Agonists as Molecular Probes for the Study of Spatiotemporal Adrenergic Signaling

Design, synthesis and pharmacological characterization of the first photoswitchable small-molecule agonist for the Atypical Chemokine Receptor 3

A high-affinity, cis-on photoswitchable beta blocker to optically control β2-adrenergic receptors in vitro and in vivo

Kinetic Basis for the Design of Azobenzene-Based Photoswitchable A 2a Adenosine Receptor Ligands

Structural basis of α 1A -adrenergic receptor activation and recognition by an extracellular nanobody

Discovery and Identification of Novel 5-Hydroxy-4 H -benzo[1,4]oxazin-3-one Derivatives as Potent β 2 -Adrenoceptor Agonists through Structure-Based Design, Synthesis, and Biological Evaluation

Optical Control of Adenosine A 2A Receptor Using Istradefylline Photosensitivity

Photoactivatable Agonist–Antagonist Pair as a Tool for Precise Spatiotemporal Control of Serotonin Receptor 2C Signaling

Chemical Synthesis of a Full-Length G-Protein-Coupled Receptor Β2-Adrenergic Receptor with Defined Modification Patterns at the C-Terminus.

Chemical Synthesis of a Full-Length G-Protein-Coupled Receptor β 2 -Adrenergic Receptor with Defined Modification Patterns at the C-Terminus

Structural insights into ligand recognition, activation, and signaling of the α 2A adrenergic receptor

Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development

Discovery of a Highly Selective β 2 -Adrenoceptor Agonist with a 2-Amino-2-phenylethanol Scaffold as an Oral Antiasthmatic Agent

Photoswitchable TCB-2 for Control of the 5-HT2A Receptor and Analysis of Biased Agonism

Distinct binding conformations of epinephrine with α- and β-adrenergic receptors

Discovery of Β-Arrestin-biased Β2-Adrenoceptor Agonists from 2-Amino-2-phenylethanol Derivatives

Noradrenaline-Specific, Efficient Visualization in Brain Tissue Triggered by Unique Cascade Nucleophilic Substitution

A novel and selective fluorescent ligand for the study of adenosine A2B receptors

Adrenoceptors: Receptors, Ligands and Their Clinical Uses, Molecular Pharmacology and Assays

Radioligands for imaging myocardial α- and β-adrenoceptors

Exploring the Deactivation Mechanism of Human Β2 Adrenergic Receptor by Accelerated Molecular Dynamic Simulations